Abstract
A case of tocainide-induced nodal bradycardia in standard recommended dose is reported. There was no recurrence when the drug was subsequently reintroduced in a reduced dosage. It is suggested that in the elderly, tocainide should be used in a lower dosage than normally recommended.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bastian B. C., Macfarlane P. W., McLauchlan J. H., Ballantyne D., Clark P., Hillis W. S., Rae A. P., Hutton I. A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J. 1980 Dec;100(6 Pt 2):1017–1022. doi: 10.1016/0002-8703(80)90207-0. [DOI] [PubMed] [Google Scholar]
- Graffner C., Conradson T. B., Hofvendahl S., Rydén L. Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction. Clin Pharmacol Ther. 1980 Jan;27(1):64–71. doi: 10.1038/clpt.1980.10. [DOI] [PubMed] [Google Scholar]
- Nyquist O., Forssell G., Nordlander R., Schenck-Gustafsson K. Hemodynamic and antiarrhythmic effects of tocainide in patients with acute myocardial infarction. Am Heart J. 1980 Dec;100(6 Pt 2):1000–1005. doi: 10.1016/0002-8703(80)90204-5. [DOI] [PubMed] [Google Scholar]